Overview
Hannah Kaizer is a Hematologist and an Oncologist in Baltimore, Maryland. Her top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, and Pure Red Cell Aplasia.
Her clinical research consists of co-authoring 7 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Specialties
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- INDEMNITY
- POS
- PPO
Locations
2401 W Belvedere Ave, Baltimore, MD 21215
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Office
Taofeek Owonikoko is a Hematologist and an Oncologist in Baltimore, Maryland. Dr. Owonikoko is highly rated in 18 conditions, according to our data. His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Tissue Biopsy.
Office
Blanche Alter is a Hematologist and an Oncologist in Rockville, Maryland. Dr. Alter is highly rated in 13 conditions, according to our data. Her top areas of expertise are Aase Syndrome, Dyskeratosis Congenita, Aplastic Anemia, Bone Marrow Transplant, and Hormone Replacement Therapy (HRT).
Office
Sharon Savage is a Hematologist and an Oncologist in Bethesda, Maryland. Dr. Savage is highly rated in 19 conditions, according to our data. Her top areas of expertise are Dyskeratosis Congenita, Aplastic Anemia, Aase Syndrome, Hormone Replacement Therapy (HRT), and Bone Marrow Transplant.
Frequently Asked Questions about Dr. Hannah Kaizer
How do I make an appointment with Dr. Hannah Kaizer?
You can book an appointment with Dr. Hannah Kaizer by calling their office at 410-871-6400. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Hannah Kaizer a top-rated expert for Acute Myeloid Leukemia (AML)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Hannah Kaizer is classified as an Experienced expert for Acute Myeloid Leukemia (AML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Hannah Kaizer specialize in?
While Dr. Hannah Kaizer is a Hematology, they have specific expertise in Acute Myeloid Leukemia (AML), Leukemia, and Pure Red Cell Aplasia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Hannah Kaizer participate in research or clinical trials?
Yes. Dr. Hannah Kaizer has published 7 articles and abstracts on conditions like Acute Myeloid Leukemia (AML). You can view a list of Dr. Hannah Kaizer's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Hannah Kaizer accept my insurance?
Dr. Hannah Kaizer accepts most major insurance plans, including Humana. We recommend calling the office directly at 410-871-6400 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Myeloid Leukemia (AML)Dr. Kaizer isExperienced. Learn about Acute Myeloid Leukemia (AML).
- LeukemiaDr. Kaizer isExperienced. Learn about Leukemia.
- Pure Red Cell AplasiaDr. Kaizer isExperienced. Learn about Pure Red Cell Aplasia.